Company
Lensar
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
8
510(k), De Novo and PMA
Device trials
4
As lead sponsor, any status
Adverse event reports
59
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
LNSR
Nasdaq · LENSAR, Inc.
Public float
$113M
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$58.4M
Fiscal year ending Dec 31, 2025
Net income
-$34.3M
Fiscal year ending Dec 31, 2025
R&D spending
$5.6M
Fiscal year ending Dec 31, 2025
Cash
$12.6M
As of Sep 30, 2026
Long-term debt
$1.9M
As of Sep 30, 2026
Shares outstanding
12.3M
As of Oct 31, 2026
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| May 12, 2023 | Equity | $20.0M | $20.0M | 1 | Rule 506(b) | Form D ↗May 26, 2023 |
| Jul 14, 2014 | Equity | $16.0M | $20.0M | 2 | Rule 506(b) | Form D/A ↗Jan 14, 20152 amendments |
| Dec 20, 2013 | Equity | $10.0M | $10.0M | 14 | Rule 506(b) | Form D ↗Jan 9, 2014 |
9 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- LENSAR, Inc.
- Headquarters
- Orlando, Florida
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- $25,000,001 - $100,000,000
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1320350 ↗
Executives, directors and promoters
As listed on the latest Form D.
9 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
K220259 · Decided Jun 9, 2022 · 129 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K182795 · Decided Dec 21, 2018 · 81 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K181430 · Decided Aug 9, 2018 · 69 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
5 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT07038395 · 46 participants · Start Jun 9, 2023 · Primary completion May 17, 2024
Device: workflow · For: Cataract
Sites: Gainesville, Georgia
NCT01062412 · 80 participants · Start Dec 2009 · Primary completion Oct 4, 2011
Device: LensAR Laser System · For: Presbyopia; Cataract
Sites: Makati City, Philippines
- Prospective Clinical Trial of the LensAR Laser SystemStatus unknown
NCT01014702 · 100 participants (planned) · Start Nov 2009 · Primary completion Jun 2011
Device: LensAR Laser System; Conventional phacoemulsification · For: Cataract
Sites: Mexico City, Mexico
1 more trials with a free account
Reports received
59
Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.
Malfunction reports
0
0.0% of reports
Injury reports
58
98% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 6 | 0 | 0 |
| Jan 24 | 0 | 6 | 0 | 0 |
| Feb 24 | 0 | 4 | 0 | 0 |
| Mar 24 | 0 | 8 | 0 | 0 |
| Apr 24 | 0 | 4 | 0 | 0 |
| May 24 | 0 | 5 | 0 | 0 |
| Jun 24 | 0 | 1 | 0 | 0 |
| Jul 24 | 0 | 6 | 0 | 0 |
| Aug 24 | 0 | 3 | 0 | 0 |
| Sep 24 | 0 | 4 | 0 | 0 |
| Oct 24 | 0 | 7 | 0 | 0 |
| Nov 24 | 0 | 9 | 0 | 0 |
| Dec 24 | 0 | 6 | 0 | 0 |
| Jan 25 | 0 | 2 | 0 | 0 |
| Feb 25 | 0 | 2 | 0 | 0 |
| Mar 25 | 0 | 7 | 0 | 0 |
| Apr 25 | 0 | 9 | 0 | 0 |
| May 25 | 0 | 2 | 0 | 0 |
| Jun 25 | 0 | 4 | 0 | 0 |
| Jul 25 | 0 | 8 | 0 | 0 |
| Aug 25 | 0 | 3 | 0 | 0 |
| Sep 25 | 0 | 4 | 0 | 0 |
| Oct 25 | 0 | 3 | 0 | 0 |
| Nov 25 | 0 | 9 | 0 | 0 |
| Dec 25 | 0 | 6 | 0 | 0 |
| Jan 26 | 0 | 1 | 0 | 0 |
| Feb 26 | 0 | 5 | 0 | 0 |
| Mar 26 | 0 | 8 | 0 | 0 |
| Apr 26 | 0 | 3 | 0 | 0 |
| May 26 | 0 | 9 | 0 | 0 |
| Jun 26 | 0 | 4 | 0 | 0 |
| Jul 26 | 0 | 8 | 0 | 0 |
| Aug 26 | 0 | 1 | 0 | 0 |
| Sep 26 | 0 | 2 | 0 | 1 |
| Oct 26 | 0 | 2 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.